Literature DB >> 26316919

Multiple Intravenous Infusions Phase 2b: Laboratory Study.

Sonia Pinkney1, Mark Fan1, Katherine Chan2, Christine Koczmara3, Christopher Colvin1, Farzan Sasangohar4, Caterina Masino1, Anthony Easty2, Patricia Trbovich5.   

Abstract

BACKGROUND: Administering multiple intravenous (IV) infusions to a single patient via infusion pump occurs routinely in health care, but there has been little empirical research examining the risks associated with this practice or ways to mitigate those risks.
OBJECTIVES: To identify the risks associated with multiple IV infusions and assess the impact of interventions on nurses' ability to safely administer them. DATA SOURCES AND REVIEW
METHODS: Forty nurses completed infusion-related tasks in a simulated adult intensive care unit, with and without interventions (i.e., repeated-measures design).
RESULTS: Errors were observed in completing common tasks associated with the administration of multiple IV infusions, including the following (all values from baseline, which was current practice): setting up and programming multiple primary continuous IV infusions (e.g., 11.7% programming errors)identifying IV infusions (e.g., 7.7% line-tracing errors)managing dead volume (e.g., 96.0% flush rate errors following IV syringe dose administration)setting up a secondary intermittent IV infusion (e.g., 11.3% secondary clamp errors)administering an IV pump bolus (e.g., 11.5% programming errors)Of 10 interventions tested, 6 (1 practice, 3 technology, and 2 educational) significantly decreased or even eliminated errors compared to baseline. LIMITATIONS: The simulation of an adult intensive care unit at 1 hospital limited the ability to generalize results. The study results were representative of nurses who received training in the interventions but had little experience using them. The longitudinal effects of the interventions were not studied.
CONCLUSIONS: Administering and managing multiple IV infusions is a complex and risk-prone activity. However, when a patient requires multiple IV infusions, targeted interventions can reduce identified risks. A combination of standardized practice, technology improvements, and targeted education is required.

Entities:  

Mesh:

Year:  2014        PMID: 26316919      PMCID: PMC4549602     

Source DB:  PubMed          Journal:  Ont Health Technol Assess Ser        ISSN: 1915-7398


  62 in total

1.  Measuring organizational traits of hospitals: the Revised Nursing Work Index.

Authors:  L H Aiken; P A Patrician
Journal:  Nurs Res       Date:  2000 May-Jun       Impact factor: 2.381

2.  Avoiding disastrous outcomes with rapid intravenous push medications.

Authors:  Susan Paparella
Journal:  J Emerg Nurs       Date:  2004-10       Impact factor: 1.836

3.  The impact of carrier flow rate and infusion set dead-volume on the dynamics of intravenous drug delivery.

Authors:  Mark A Lovich; Jason Doles; Robert A Peterfreund
Journal:  Anesth Analg       Date:  2005-04       Impact factor: 5.108

Review 4.  A concept analysis of the phenomenon interruption.

Authors:  Juliana J Brixey; David J Robinson; Craig W Johnson; Todd R Johnson; James P Turley; Jiajie Zhang
Journal:  ANS Adv Nurs Sci       Date:  2007 Jan-Mar       Impact factor: 1.824

Review 5.  Taking aim at infusion confusion.

Authors:  Gabrielle Burdeu; Ruth Crawford; Melita van de Vreede; Joanne McCann
Journal:  J Nurs Care Qual       Date:  2006 Apr-Jun       Impact factor: 1.597

6.  Central venous catheter infusions: a laboratory model shows large differences in drug delivery dynamics related to catheter dead volume.

Authors:  Mark A Lovich; Gregory L Peterfreund; Nathaniel M Sims; Robert A Peterfreund
Journal:  Crit Care Med       Date:  2007-12       Impact factor: 7.598

7.  An in vitro analysis of central venous drug delivery by continuous infusion: the effect of manifold design and port selection.

Authors:  David R Moss; Karsten Bartels; Gregory L Peterfreund; Mark A Lovich; Nathaniel M Sims; Robert A Peterfreund
Journal:  Anesth Analg       Date:  2009-11       Impact factor: 5.108

8.  "Smart" infusion pumps are selectively intelligent.

Authors:  Kathleen Cummings; Ryan McGowan
Journal:  Nursing       Date:  2011-03

9.  Analysis of risk factors for adverse drug events in critically ill patients*.

Authors:  Sandra L Kane-Gill; Levent Kirisci; Margaret M Verrico; Jeffrey M Rothschild
Journal:  Crit Care Med       Date:  2012-03       Impact factor: 7.598

10.  The impact of traditional and smart pump infusion technology on nurse medication administration performance in a simulated inpatient unit.

Authors:  P L Trbovich; S Pinkney; J A Cafazzo; A C Easty
Journal:  Qual Saf Health Care       Date:  2010-04-27
View more
  6 in total

1.  Direct Observational Study of Interfaced Smart-Pumps in Pediatric Intensive Care.

Authors:  Moninne M Howlett; Cormac V Breatnach; Erika Brereton; Brian J Cleary
Journal:  Appl Clin Inform       Date:  2020-10-07       Impact factor: 2.342

2.  Clinical observations and a ealthcare ailure ode and ffect nalysis to identify vulnerabilities in the security and accounting of medications in Ontario hospitals: a study protocol.

Authors:  Maaike de Vries; Mark Fan; Dorothy Tscheng; Michael Hamilton; Patricia Trbovich
Journal:  BMJ Open       Date:  2019-06-29       Impact factor: 2.692

3.  Untangling Infusion Confusion: A Comparative Evaluation of Interventions in a Simulated Intensive Care Setting.

Authors:  Sonia J Pinkney; Mark Fan; Christine Koczmara; Patricia L Trbovich
Journal:  Crit Care Med       Date:  2019-07       Impact factor: 7.598

4.  Quantitative assessment of required separator fluid volume in multi-infusion settings.

Authors:  Frank Doesburg; Daniek Middendorp; Willem Dieperink; Wouter Bult; Maarten W Nijsten; Daan J Touw
Journal:  J Vasc Access       Date:  2020-05-04       Impact factor: 2.283

5.  The effect of concentration, reconstitution solution and pH on the stability of a remifentanil hydrochloride and propofol admixture for simultaneous co-infusion.

Authors:  Emily Henkel; Rebecca Vella; Kieran Behan; David Austin; Peter Kruger; Andrew Fenning
Journal:  BMC Anesthesiol       Date:  2020-11-12       Impact factor: 2.217

Review 6.  [Update of the recommendations of the Bacteraemia Zero Project].

Authors:  E Gallart; M Delicado; X Nuvials
Journal:  Enferm Intensiva       Date:  2022-07-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.